Member Info for Trickymatters

We had an announcement on this on April 10th- about �75 million fund for prostate cancer research including technologies to support early detection. We've also had a pledge for a doubling of funding for brain cancer research, particularly that which supports early detection. So VAL could be a candidate for funding for 201 and 101. We should hear soon about who's in shouldn't we?

Good article Apple. Thanks for sharing it.

Oh dear, Damo, why on earth would you base investment decisions on anything Robot says? A couple of people have rightly, in my view, noted his rambling, misspelt comments are completely incoherent half the time. Maybe look for contributions that make sense and double check sources yourself wherever possible. We came off 1.40 from a short attack. Shorts are nearly out now. Big companies don't make much impact if they have less than 0.5%- harder for them to stimulate a reaction from the rest of us and it's illegal for them to co-ordinate. We're only now back to the low end of the more typical price range for us over the last year. You can have a look at graphs on this site. We're coming up to the annual report and a fortnight later the results for the first quarter and forward guidance should be out.

Damo1176, how do you work that out? I don't see how anyone knows what undisclosed shorts there are. 1.5% disclosed shorts shows that the big players are getting out. There were quite a few companies shorting. If a couple are still here at less than 0.5% you'd think they want out before the annual report and certainly before results are due. They'll have to close or lose money.

https://shorttracker.co.uk/company/JE00BG6L7297/ Good news. Only AHL and the Canadian Pension Plan still in.

Clearly they aren't financially committed yet. It costs time and money to engage in the MOU agreement. It's a strong indication of Possehl's interest and commitment. There are three possibilities for a near term commercial proposition which this hinges on. I've summarised those in my post and you've later repeated the three opportunities in a separate post- Storuman, Nevada and an as yet unnamed new acquisition.

for Boo to �3.25. A lot happening now. The Pepsi deal is a sign of Boo becoming a major brand in retail - they're reach will extend - maybe from an 'early majority' to a much bigger market. Results are always fantastic, exceeding expectations every time. The last set of results were phenomenal- sales nearly doubling in some contexts for goodness sake. I am thinking I should re-adjust my target to �2.90 from �2.80.

Storuman sounds very positive. They're getting some-one new into Nevada to help and Norway is still on the back burner. Due diligence for a new acquisition is actually a small step forward. There's no way Posseuhl are engaging in this unless they believe it's a goer.

I'm predicting a 2.10 close today ;)

Off the top of my head- small bio-tech companies bought up by big pharma (I only know because I had shares in one or the other of these companies- in 2017 Novartis agreed a joint venture with Oxford Biomedica; and Gilead Science bought Kite. We don't necessarily need a British pharma.

Trader 50- you must have heard of Siemens? They are the biggest engineering company in Europe- though obviously they have huge infrastructure projects of all kinds all over the world. Very bullish at the moment- up from 101 Euros to 115 in a couple of weeks. Target from most brokers is over 130. Last results had them exceeding forecasts with 40% profits this year.

In two weeks time the GDP Regulations from Europe, which the UK government has also adopted, will require every single firm which gets hacked to publish and report the experience within 72 hours. Dozens of big firms are hacked every year. Huge fines will also be introduced. Firms have to ensure that their suppliers are also compliant with proper cybersecurity protection. Putting data in the cloud is no escape! I expect those firms who successfully protect their clients will also come into focus very soon. Think on the implications for this very effective and well placed cyber security firm- with new high powered and well connected non exec Director in place now too.

Based on the obscure logic that the last appeal took 6 weeks - before deciding in our favour. The deadline for submission of responses to additional enquiries was 17th April. 23rd May is 6 weeks, allowing another day for the Bank Holiday and assuming the decision would be released the day after. What do you think PIs?

who of Citibank, an International Investment Bank has put his money in VAL. Exciting news hey?

I'm thinking at least 210 by the 25th May if that's the day they publish the audited accounts. Some big buyers showing a lot of confidence in Boo yesterday hey?

Buys are close to 50% up on sells so far today but we've got a little dip in the sp. Close to 2 million shares traded so I don't understand that trajectory.

Cor blimey.

Me too. The only consolation I suppose is that if any of VAL's pipeline starts to look extremely promising at stage 3 clinical trials (where VAL 401 is), these worries about share dilution will become irrelevant. If we are first in line with any successful treatment for these four diseases (or more considering the flexibility for developing VAL 301) we won't be a penny share anymore or we'll get bought out, lock, stock and barrel. You can bet this board will get their money's worth if we get bought out- so, so will we!

Our market cap is �5.39 million. The resources at Storuman are worth twenty times that. What do you think it'll be worth for the company and the share price- short term and long term?

If all goes to plan this will be on a trajectory to the moon starting Friday or Monday. My guess is 30p within a week of an agreement to turn that MOU into an offtake. Come on SGU!